1. |
WHO. Globalcan Database. http//www-depdb.iare.fr, 2004-11-20.
|
2. |
周岱翰, 林麗珠, 周宜強, 等. 非小細胞肺癌三種治療方案的成本-效果分析. 中國腫瘤臨床, 2005, 32(19): 1081-1084.
|
3. |
Molinier L, Combescure C , Chouaid C, et al. Cost of lung cancer: a methodological review. Pharmacoeconomics, 2006, 24(7): 651-659.
|
4. |
ChapterⅡ. 5 Cost of Lung Cancer, www.epa.gov/oppt/coi/docs/Ⅱ _5.pdf, 2005-01-10.
|
5. |
Chouaid C, Molinier L, Combescure C, et al. Economics of the clinical management of lung cancer in France: an analysis using a Markov model. Br J Cancer, 2004, 90(2): 397-402.
|
6. |
Evans WK, Will BP, Berthelot JM, et al. The economics of lung cancer management in Canada. Lung Cancer, 1996, 14(1): 19-29.
|
7. |
Braud AC, Lévy-Piedbois C, Piedbois P, et al. Direct treatment costs for patients with lung cancer from first recurrence to death in france. Pharmacoeconomics. 2003, 21(9): 671-679.
|
8. |
Welcker K, Marian P, Thetter O, et al. Cost and quality of life in thoracic surgery--a health economic analysis in a German center. Thorac Cardiovasc Surg, 2003, 51(5): 260-266.
|
9. |
Wolstenholme JL, Whynes DK. The hospital costs of treating lung cancer in the United Kingdom. Br J Cancer, 1999, 80(1-2): 215-218..
|
10. |
Tschopp JM, Brutsche M, Frey JG, et al. Thoracic surgery for nonsmall cell lung cancer. Cost-benefit of its management in specialized intermediate care. Swiss Surg Suppl, 1996, Suppl 1: 46-51.
|
11. |
Demeter SJ, Jacobs P, Chmielowiec C, et al. The cost of lung cancer in Alberta. Can Respir J, 2007, 14(2): 81-86.
|
12. |
Arca JA, Ramos MA, de la Infanta RG, et al. Lung cancer diagnosis: hospitalization costs. Arch Bronconeumol, 2006, 42(11): 569-574.
|
13. |
Hillner BE, McDonald MK, Desch CE, et al. Costs of care associated with non-small-cell lung cancer in a commercially insured cohort. J Clin Oncol, 1998, 16(4): 1420-1424.
|
14. |
Dedes KJ, Szucs TD, Bodis S, et al. Management and costs of treating lung cancer patients in a university hospital. Pharmacoeconomics, 2004, 22(7): 435-444.
|